Rekha Hemrajani
Director/Board Member at MAXCYTE, INC.
Net worth: 50 610 $ as of 2024-04-29
Network origin in Rekha Hemrajani first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 36 | |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA.
23
| Subsidiary | Pharmaceuticals: Major | 23 |
| Public Company | Biotechnology | 22 | |
| Public Company | Pharmaceuticals: Major | 22 | |
| Public Company | Biotechnology | 21 | |
| Private Company | Financial Conglomerates | 9 | |
| Public Company | Pharmaceuticals: Major | 7 | |
| Public Company | Biotechnology | 6 | |
BioAge Labs, Inc.
 BioAge Labs, Inc. BiotechnologyHealth Technology BioAge Labs, Inc. develops biological products. It offers data with machine learning to measure human aging and accelerate drug discovery. The company was founded by Kristen Fortney and is headquartered in Berkeley, CA.
5
| Holding Company | Biotechnology | 5 |
| Public Company | Biotechnology | 5 | |
ALX Oncology, Inc.
 ALX Oncology, Inc. Pharmaceuticals: MajorHealth Technology Part of ALX Oncology Holdings, Inc., ALX Oncology, Inc. operates as a clinical-stage immuno-oncology company which develops therapies for cancers. The company is based in Burlingame, CA. The CEO of the company is Jaume Pons.
3
| Subsidiary | Pharmaceuticals: Major | 3 |
Hemmo Pharmaceuticals Pvt Ltd.
 Hemmo Pharmaceuticals Pvt Ltd. Pharmaceuticals: MajorHealth Technology Part of Piramal Pharma Ltd., Hemmo Pharmaceuticals Pvt Ltd. is an Indian company that develops and manufactures peptide APIs. The company is based in Mumbai, India. The CEO of the company is Madhu Vikram Utamsingh. Hemmo Pharmaceuticals was acquired by Piramal Pharma Ltd. on June 22, 2021 for $105.61 million.
2
| Subsidiary | Pharmaceuticals: Major | 2 |
| Public Company | Pharmaceuticals: Major | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Rekha Hemrajani via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| University of California, Berkeley | College/University | Undergraduate Degree Corporate Officer/Principal Undergraduate Degree Doctorate Degree Graduate Degree Doctorate Degree Undergraduate Degree Undergraduate Degree Doctorate Degree Doctorate Degree | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Treasurer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| Stanford University | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree Undergraduate Degree Doctorate Degree Undergraduate Degree Undergraduate Degree Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal Director/Board Member | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Corporate Officer/Principal Doctorate Degree Doctorate Degree Undergraduate Degree Undergraduate Degree | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Corporate Officer/Principal Director/Board Member Director/Board Member | |
Samsara Biocapital LLC
 Samsara Biocapital LLC Investment ManagersFinance Samsara Biocapital LLC (Samsara Biocapital) is an independent venture capital firm founded in 2016 by Srinivas Akkaraju. The firm is headquartered in Palo Alto, California. | Investment Managers | Founder Consultant / Advisor Private Equity Investor Director of Finance/CFO Private Equity Investor | |
| Kellogg School of Management | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
Sofinnova Investments, Inc.
 Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment Inc (Sofinnova Investment) is a venture capital firm founded in 1976 by Jacques F. vallle & Joel F. Martin. The firm is headquartered in Menlo Park, California. | Investment Managers | Private Equity Investor Corporate Officer/Principal Private Equity Investor Private Equity Investor | |
| AMGEN INC. | Pharmaceuticals: Major | General Counsel Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal | |
| OLEMA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer Director/Board Member | |
| University of Cambridge | College/University | Doctorate Degree Doctorate Degree Doctorate Degree Graduate Degree | |
| University of California, Los Angeles | College/University | Graduate Degree Masters Business Admin Doctorate Degree Undergraduate Degree | |
| The Johns Hopkins University | College/University | Undergraduate Degree Masters Business Admin Undergraduate Degree | |
MPM BioImpact, Inc
 MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Corporate Officer/Principal Private Equity Investor Private Equity Investor | |
| NOVAVAX, INC. | Biotechnology | Director/Board Member Chief Executive Officer Director/Board Member | |
| SANGAMO THERAPEUTICS, INC. | Biotechnology | Chairman Director/Board Member Director/Board Member | |
LSV CAPITAL MANAGEMENT LLC
 LSV CAPITAL MANAGEMENT LLC Investment ManagersFinance LSV Capital Management LLC (Lightstone Ventures) is a venture capital firm founded in 2012. The firm is headquartered in Menlo Park, California. | Investment Managers | Private Equity Investor Consultant / Advisor Consultant / Advisor | |
| ALLERGAN, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Tallac Therapeutics, Inc.
 Tallac Therapeutics, Inc. BiotechnologyHealth Technology Tallac Therapeutics, Inc. engages in the development of immunomodulating polynucleotides. The company is headquartered in Burlingame, CA. | Biotechnology | Director/Board Member Director/Board Member Founder | |
SillaJen Biotherapeutics, Inc.
 SillaJen Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services SillaJen Biotherapeutics, Inc. develops and commercializes cancer therapeutics. It focuses on the development and commercialization of first-in-class, breakthrough targeted oncolytic immunotherapy products for solid tumors. It is focused on two main programs, lead product candidate, which is in mid-stage clinical development for the treatment of advanced primary liver cancer and colorectal cancer and JX-929 which is under investigation for a variety of other solid tumors. The company was founded by John C. Bell and David H. Kirn in 2006 and is headquartered in San Francisco, CA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Chief Executive Officer | |
| University of San Francisco | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Graduate Degree Doctorate Degree | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Graduate Degree Undergraduate Degree Undergraduate Degree | |
Autobahn Labs, Inc.
 Autobahn Labs, Inc. Medical/Nursing ServicesHealth Services Autobahn Labs, Inc. is a virtual incubator that partners with research institutions to accelerate the advancement of early-stage drug discovery and development. The company is based in Palo Alto, CA. The organization invests intellectual, financial, and physical capital to efficiently move projects from feasibility to novel drug candidates. Autobahn Labs was created by Samsara Biocapital, Evotec, and KCK Ltd. | Medical/Nursing Services | Director/Board Member Chairman Director of Finance/CFO | |
Human Genome Sciences, Inc.
 Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Tizona Therapeutics, Inc.
 Tizona Therapeutics, Inc. BiotechnologyHealth Technology Tizona Therapeutics, Inc. is an immunology company harnessing the power of the immune system to develop treatments for cancer and autoimmune diseases. Its products include anti-ccr4 antibody for the treatment of cancer, il-35 antagonists for the treatment of cancer, and il-35 agonists for the treatment of autoimmune diseases. The company was founded by Charles G. Drake, Vijay K. Kuchroo, Drew M. Pardoll, Dario Vignali, Wayne A. Marasco and Jedd D. Wolchok and is headquartered in South San Francisco, CA. | Biotechnology | Chief Executive Officer Chairman Director of Finance/CFO | |
National Institutes of Health
 National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | General Government | Corporate Officer/Principal Director/Board Member Corporate Officer/Principal | |
venBio Partners LLC
 venBio Partners LLC Investment ManagersFinance venBio Partners LLC (venBio) is a venture capital subsidiary of Venbio Partners LP founded in 2009 by Adelman robert and Goodman corey. The firm is headquartered in San Francisco, California. | Investment Managers | Founder Founder Private Equity Investor | |
Alx Oncology Ltd.
 Alx Oncology Ltd. Pharmaceuticals: MajorHealth Technology Alx Oncology Ltd. operates as biotechnology company developing immuno-oncology therapies for cancer. The company was founded by Kipp Weiskopf and Jaume Pons in 2015 and is headquartered in Ireland, Dublin. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Founder | |
| ARYX THERAPEUTICS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Chairman Director/Board Member | |
| ALDER BIOPHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Executive Officer General Counsel | |
Labrys Biologics, Inc.
 Labrys Biologics, Inc. BiotechnologyHealth Technology Labrys Biologics, Inc. provides biotechnology services. It is a venture-financed development stage biotechnology company, which focuses on treatments for chronic migraine. The company was founded by Corey S. Goodman in 2012 and is headquartered in San Francisco, CA. | Biotechnology | Corporate Officer/Principal Founder Corporate Officer/Principal | |
| University of Michigan | College/University | Corporate Officer/Principal Undergraduate Degree Doctorate Degree | |
| RELYPSA INC | Pharmaceuticals: Major | President Chairman Founder | |
DuPont Merck Pharmaceutical Co.
 DuPont Merck Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Part of Corteva, Inc., DuPont Merck Pharmaceutical Co. is a company that makes pharmaceuticals and drugs. The company is based in Wilmington, DE. DuPont Merck Pharmaceutical was acquired by EIDP, Inc., a subsidiary of Corteva, Inc. from Merck & Co., Inc. on July 01, 1998 for $2,600 million. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| University of California San Diego | College/University | Director/Board Member Undergraduate Degree | |
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
| LUMINEX CORPORATION | Medical Specialties | Chief Executive Officer Director/Board Member | |
| PANACOS PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| XENOPORT, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| MYRIAD GENETICS, INC. | Medical Specialties | Director/Board Member Corporate Officer/Principal | |
| NURIX THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| AMBIT BIOSCIENCES CORP | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
| University of California, Davis | College/University | Undergraduate Degree Undergraduate Degree |
Statistics
International
| United States | 48 |
| Ireland | 3 |
| United Kingdom | 2 |
Sectoral
| Health Technology | 28 |
| Consumer Services | 13 |
| Finance | 7 |
| Commercial Services | 3 |
| Health Services | 3 |
Operational
| Director/Board Member | 652 |
| Corporate Officer/Principal | 267 |
| Independent Dir/Board Member | 226 |
| Chairman | 117 |
| Undergraduate Degree | 83 |
Most connected contacts
| Insiders | |
|---|---|
| Srini Akkaraju Akkaraju | 54 |
| Geoff Duyk | 42 |
| Jack Nielsen | 38 |
| Perry Karsen | 38 |
| Corey Goodman | 35 |
| Fred Eshelman | 34 |
| William Ringo | 32 |
| Reed Tuckson | 31 |
| Thomas Wiggans | 31 |
| Jay Shepard | 30 |
| Dov Goldstein | 28 |
| Jim Scopa | 26 |
| Mitchell Finer | 26 |
| Robert J. Adelman | 25 |
| Mohammed Malik | 24 |
- Stock Market
- Insiders
- Rekha Hemrajani
- Company connections
